<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-64131</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Bacterial biofilms are very resistant to antimicrobial activity. The concentration of drugs required to achieve bactericidal activity may be several orders of magnitude higher than the sensitivity for planktonic bacteria, since it is very difficult to completely sterilize infected surfaces. Biofilm antimicrobial resistance is a multifactorial process and is mainly related to the structural and physiological characteristics of the biofilms. Various control strategies have been designed to inhibit biofilm formation on medical devices, in most cases with little success. The most important mechanisms of biofilm resistance to antimicrobial agents and their effect on the activity of the main groups of antimicrobials are discussed (AU)</dc:description>
<dc:creator>Pascual, Álvaro</dc:creator>
<dc:creator>Rodríguez-Martínez, José Manuel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Las bacterias presentes en las biocapas bacterianas son muy resistentes a los tratamientos antimicrobianos; tanto es así, que la concentración requerida para alcanzar actividad bactericida puede ser de varios órdenes de magnitud comparada con la sensibilidad de bacterias planctónicas, y es extremadamente complicado esterilizar completamente las superficies colonizadas. Este tipo de resistencia es multifactorial y atiende fundamentalmente a las características estructurales y fisiológicas de la biocapa. Se han diseñado diversas estrategias de control para inhibir la formación de biocapas sobre dispositivos médicos, con escaso éxito en la mayoría de los casos. En este documento discutimos los principales mecanismos de resistencia asociados a biocapas bacterianas y su efecto sobre la actividad de los principales grupos de antimicrobianos (AU)</dc:description>
<dc:source>Enferm Infecc Microbiol Clin;26(2): 107-114, feb. 2008. ilus, tab</dc:source>
<dc:identifier>ibc-64131</dc:identifier>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d32342^s22021</dc:subject>
<dc:subject>^d911^s22079</dc:subject>
<dc:subject>^d1696</dc:subject>
<dc:subject>^d29867^s22057</dc:subject>
<dc:subject>^d11365^s22021</dc:subject>
<dc:subject>^d25122</dc:subject>
<dc:type>article</dc:type>
<dc:date>200802</dc:date>
</metadata>
</record>
</ibecs-document>
